Stay updated on Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page.

Latest updates to the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page has undergone significant content changes, particularly the removal of detailed information regarding a clinical trial for ZX008 (fenfluramine hydrochloride) in treating Dravet syndrome, including key inclusion and exclusion criteria. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference21%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check84 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check99 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page.